These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4446204)

  • 1. Urokinase inhibitor in patients with bladder cancer.
    Hisazumi H; Naito K; Misaki T; Kosaka S
    Urol Res; 1974 Dec; 2(3):137-42. PubMed ID: 4446204
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis-inhibitory activity of cultured human cancer cell lines.
    Naito S; Kinjo M; Nanno S; Kohga S; Oka K; Tanaka K
    Gan; 1981 Feb; 72(1):1-7. PubMed ID: 6456167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
    Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E
    Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator and its receptor in bladder cancer.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 May; 89(10):678-9. PubMed ID: 9168177
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Duffy MJ; Duggan C
    J Natl Cancer Inst; 1997 Nov; 89(21):1628-30. PubMed ID: 9362165
    [No Abstract]   [Full Text] [Related]  

  • 7. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    See WA
    J Natl Cancer Inst; 1998 Sep; 90(17):1303. PubMed ID: 9731738
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 Nov; 89(21):1630-1. PubMed ID: 9362166
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolytic activity of in vitro cultivated human bladder cell lines.
    Hisazumi H; Andersson L; Collins VP
    Urol Res; 1977; 5(3):133-9. PubMed ID: 144345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthetic inhibitors of serine proteinases. 17. The effect of benzamidine derivatives on the activity of urokinase and the reduction of fibrinolysis].
    Stürzebecher J; Markwardt F
    Pharmazie; 1978 Sep; 33(9):599-602. PubMed ID: 733877
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urokinase inhibitors in blood serum samples from retroplacental blood].
    Uszyński M; Uszyńska-Folejewska R
    Ginekol Pol; 1975 Jul; 46(7):737-9. PubMed ID: 1150101
    [No Abstract]   [Full Text] [Related]  

  • 13. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
    Walker JE; Gow L; Campbell DM; Ogston D
    Thromb Haemost; 1983 Feb; 49(1):21-3. PubMed ID: 6221434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of urokinase-related fibrinolytic activity in human plasma.
    Wijngaards G; Kluft C; Groeneveld E
    Br J Haematol; 1982 May; 51(1):165-9. PubMed ID: 7041952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of peptides with anti-urokinase activity from the human placenta.
    Uszynski M
    Thromb Haemost; 1980 Feb; 42(5):1411-6. PubMed ID: 6768150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer.
    Hasui Y; Marutsuka K; Suzumiya J; Kitada S; Osada Y; Sumiyoshi A
    Int J Cancer; 1992 Apr; 50(6):871-3. PubMed ID: 1555885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the plasminogen activator urokinase by alpha-tocopherol.
    Ogston D
    Acta Haematol; 1982; 67(2):114-8. PubMed ID: 6801892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on plasminogen activator activity in cancerous tissues of the bladder (author's transl)].
    Kojima A
    Nihon Hinyokika Gakkai Zasshi; 1975 Nov; 66(11):753-60. PubMed ID: 1239627
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene.
    Brunner G; Pohl J; Erkell LJ; Radler-Pohl A; Schirrmacher V
    J Cancer Res Clin Oncol; 1989; 115(2):139-44. PubMed ID: 2654132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.